Stimcell Energetics (STME) EBIT Margin (2016 - 2023)
Stimcell Energetics' (STME) quarterly EBIT Margin came in at 87531.08% in Q2 2023, down 7454827.0% year-on-year from N/an in Q2 2022, and down 83.61% quarter-over-quarter from 47672.07% in Q1 2023.
Stimcell Energetics (STME) EBIT Margin (2016 - 2023) Analysis & Trends
Stimcell Energetics' EBIT Margin history runs 7 years deep, the most recent figure standing at 87531.08% for Q2 2023.
- On a quarterly basis, EBIT Margin fell 7454827.0% year-over-year to 87531.08% in Q2 2023; TTM through Feb 2024 was 292113.51%, a 27249382.0% decrease from a year earlier, with the FY2023 full-year figure at 16207.75%, up 1193188.0% from the prior year.
- EBIT Margin fell to 87531.08% in Q2 2023 per STME's latest filing, from 47672.07% in the prior quarter.
- Across five years, EBIT Margin topped out at 322.97% in Q2 2020 and bottomed at 87531.08% in Q2 2023.
- The 5-year median for EBIT Margin is 13129.31% (2022), against an average of 19290.5%.
- Across the five-year window, EBIT Margin jumped 254179 bps in 2021 and sank 7454827 bps in 2023, its largest moves.
- Year by year, EBIT Margin stood at 2927.66% in 2019, then plunged by 231 bps to 9698.4% in 2020, then retreated by 5 bps to 10205.57% in 2021, then sank by 59 bps to 16262.19% in 2022, then plunged by 438 bps to 87531.08% in 2023.
- Per Business Quant, the three latest STME EBIT Margin figures stand at 87531.08% (Q2 2023), 47672.07% (Q1 2023), and 16262.19% (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | -87,531.08% |
| Feb 28, 2023 | -47,672.07% |
| Nov 30, 2022 | -16,262.19% |
| Aug 31, 2022 | -28,101.55% |
| May 31, 2022 | -12,982.81% |
| Feb 28, 2022 | -26,691.94% |
| Nov 30, 2021 | -10,205.57% |
| Aug 31, 2021 | -19,583.29% |
| May 31, 2021 | -13,395.73% |
| Feb 28, 2021 | -8,140.57% |
| Nov 30, 2020 | -9,698.40% |
| Aug 31, 2020 | -13,275.80% |
| May 31, 2020 | -322.97% |
| Feb 29, 2020 | -10,682.35% |
| Nov 30, 2019 | -2,927.66% |
| Aug 31, 2019 | -1,174.01% |
| Feb 28, 2017 | -56,944.77% |
| Nov 30, 2016 | -71,928.27% |
| Aug 31, 2016 | -4,790.74% |
| May 31, 2016 | -1,116.97% |